Company page
Cellectis S.a.
Cellectis S.A. is a public biotechnology company based in France, trading under the ticker ALCLS. The company focuses on developing innovative gene-editing technologies for therapeutic applications. With a market capitalization of approximately €202.56 million, Cellectis aims to advance its research and development efforts in the field of genomics.
- Ticker
- ALCLS:EURONEXT
- Asset type
- Stock
- Market cap
- $261.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- EURONEXT
- Currency
- EUR